Display options
Share it on

Cytojournal. 2010 Apr 06;7:5. doi: 10.4103/1742-6413.62257.

Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH.

CytoJournal

Hatem Q Al-Maghraby, Walid E Khalbuss, Uma N M Rao, Kathleen Cieply, Sanja Dacic, Sara E Monaco

Affiliations

  1. Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto, Ontario, Canada.

PMID: 20436789 PMCID: PMC2861822 DOI: 10.4103/1742-6413.62257

Abstract

Lipomatous mesenchymal tumors constitute the most common type of soft tissue tumors. Well-differentiated liposarcoma (WDLS) can undergo dedifferentiation to a nonlipogenic sarcoma of variable histologic grade. In the recent literature, amplification of the murine double minute 2 (MDM2) oncogene, which has a role in cell cycle control, has been successful in distinguishing WDLS from benign lesions. We present a case of dedifferentiated liposarcoma diagnosed by fine-needle aspiration (FNA), using cytomorphology and ancillary studies (immunocytochemistry and fluorescent in-situ hybridization). An 85-year old female presented to our institution with a firm soft tissue mass of the right buttock. The FNA showed atypical spindle cells, osteoclast-like giant cells and extracellular dense matrix material. The cell block showed cellular groups of highly atypical spindle cells with osteoid and adipose tissue. Fluorescence in situ hybridization (FISH) studies performed on the cell block demonstrated amplification of the MDM2 gene. In addition, the findings were morphologically compatible with the previously resected retroperitoneal dedifferentiated liposarcoma with areas of osteosarcoma. This rare case illustrates the usefulness of FNA and ancillary studies in the diagnosis and subclassification of soft tissue tumors. To the best of our knowledge, this is the first report of MDM2 FISH positivity in a liposarcoma diagnosed by FNA.

Keywords: Cytopathology; MDM2; fine needle aspiration biopsy liposarcoma

References

  1. Cytopathology. 2009 Jun;20(3):195-8 - PubMed
  2. J Pathol. 2004 Jul;203(3):822-30 - PubMed
  3. Cancer Genet Cytogenet. 1997 Nov;99(1):14-8 - PubMed
  4. Nature. 1993 Jun 17;363(6430):640-4 - PubMed
  5. Mod Pathol. 2008 Aug;21(8):943-9 - PubMed
  6. Am J Surg Pathol. 1992 Nov;16(11):1051-8 - PubMed
  7. Cancer Res. 1995 Jan 1;55(1):24-7 - PubMed
  8. Am J Surg Pathol. 2005 Oct;29(10):1340-7 - PubMed
  9. Ann Diagn Pathol. 2000 Aug;4(4):252-66 - PubMed
  10. Mod Pathol. 2003 Mar;16(3):256-62 - PubMed
  11. Cancer Genet Cytogenet. 1986 Dec;23(4):291-9 - PubMed
  12. J Natl Cancer Inst. 1994 Sep 7;86(17):1297-302 - PubMed
  13. Mod Pathol. 2009 Jan;22(1):66-70 - PubMed
  14. Am J Surg Pathol. 1997 Mar;21(3):271-81 - PubMed
  15. Hum Pathol. 1997 Feb;28(2):134-42 - PubMed
  16. Adv Cancer Res. 2003;89:1-34 - PubMed
  17. Am J Surg Pathol. 1994 Dec;18(12):1213-23 - PubMed
  18. Mod Pathol. 2004 Jun;17(6):660-9 - PubMed
  19. Am J Surg Pathol. 2009 Nov;33(11):1594-600 - PubMed
  20. Genes Chromosomes Cancer. 2006 May;45(5):447-54 - PubMed
  21. Am J Surg Pathol. 2007 Oct;31(10):1476-89 - PubMed
  22. J Pathol. 1998 Jun;185(2):188-90 - PubMed
  23. Ultrastruct Pathol. 2008 Mar-Apr;32(2):63-71 - PubMed
  24. Diagn Cytopathol. 2007 Nov;35(11):734-7 - PubMed

Publication Types